Interpretation of trial-based economic evaluations of musculoskeletal physical therapy interventions

Drummond, 2005 Tordrup, 2014, Consolidated research agenda needed for health economic evaluation in Europe, BMJ, 349, g5228, 10.1136/bmj.g5228 2008 Moraz, 2015, Estudos de custo-efetividade em saúde no Brasil: uma revisão sistemática, Cienc Saude Colet, 20, 3211, 10.1590/1413-812320152010.00962015 Drake, 2016, Dynamic transmission economic evaluation of infectious disease interventions in low- and middle-income countries: A systematic literature review, Health Econ, 25, 124, 10.1002/hec.3303 2016, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1545, 10.1016/S0140-6736(16)31678-6 Jackson, 2016, A systematic review and meta-analysis of the global burden of chronic pain without clear etiology in low- and middle-income countries: Trends in heterogeneous data and a proposal for new assessment methods, Anesth Analg, 123, 739, 10.1213/ANE.0000000000001389 Lalonde, 2014, Costs of moderate to severe chronic pain in primary care patients - a study of the ACCORD Program, J Pain Res, 7, 389, 10.2147/JPR.S55388 Breivik, 2013, Openminds. The individual and societal burden of chronic pain in Europe: The case for strategic prioritisation and action to improve knowledge and availability of appropriate care, BMC Public Health, 13, 1229, 10.1186/1471-2458-13-1229 Dieleman, 2020, US health care spending by payer and health condition, 1996-2016, JAMA, 323, 863, 10.1001/jama.2020.0734 Bevan, 2015, Economic impact of musculoskeletal disorders (MSDs) on work in Europe, Best Pract Res Cl Rh, 29, 356, 10.1016/j.berh.2015.08.002 Dagenais, 2008, A systematic review of low back pain cost of illness studies in the United States and internationally, Spine J, 8, 8, 10.1016/j.spinee.2007.10.005 Salary converter: purchasing power parities. http://salaryconverter.nigelb.me/. Updated February. Accessed 2017. Carregaro, 2019, Direct healthcare costs of spinal disorders in Brazil, Int J Public Health, 64, 965, 10.1007/s00038-019-01211-6 Carregaro, 2020, Low back pain should be considered a health and research priority in Brazil: Lost productivity and healthcare costs between 2012 to 2016, PloS one, 15, 10.1371/journal.pone.0230902 Buchbinder, 2020, The Lancet Series call to action to reduce low value care for low back pain: an update, Pain, 161, S57, 10.1097/j.pain.0000000000001869 Foster, 2018, Prevention and treatment of low back pain: Evidence, challenges, and promising directions, Lancet, 391, 2368, 10.1016/S0140-6736(18)30489-6 van der Roer, 2006, Economic evaluations: A new avenue of outcome assessment in spinal disorders, Eur Spine J, 15, S109, 10.1007/s00586-005-1052-x Decimoni, 2018, Systematic review of health economic evaluation studies developed in brazil from 1980 to 2013, Front Public Health, 6, 52, 10.3389/fpubh.2018.00052 Kanters, 2017, Update of the Dutch manual for costing studies in health care, PloS one, 12, 10.1371/journal.pone.0187477 Rede Brasileira de Avaliação de Tecnologias em Saúde. http://rebrats.saude.gov.br. Published 2020. Accessed. Rede Brasileira de Avaliação de Tecnologias em Saúde (REBRATS). Diretriz de Avaliação Econômica. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Gestão e Incorporação de Tecnologias em Saúde. REBRATS. http://rebrats.saude.gov.br/diretrizes-metodologicas. Updated 2013. Accessed 2017. Peter, 2011, Physiotherapy in hip and knee osteoarthritis: development of a practice guideline concerning initial assessment, treatment and evaluation, Acta Reumatol Port, 36, 268 Childs, 2008, Neck pain: clinical practice guidelines linked to the international classification of functioning, disability, and health from the orthopedic section of the american physical therapy association, J Orthop Sports Phys Ther, 38, A1, 10.2519/jospt.2008.0303 Qaseem, 2017, Clinical Guidelines Committee of the American College of P. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians, Ann Intern Med, 166, 514, 10.7326/M16-2367 van Dongen, 2016, Health economic evidence gaps and methodological constraints in low back pain and neck pain: results of the research agenda for health economic evaluation (RAHEE) project, Best Pract Res Cl Rh, 30, 981, 10.1016/j.berh.2017.09.001 Roseboom, 2017, Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators, BMC Health Serv Res, 17, 89, 10.1186/s12913-017-1986-9 Eddama, 2008, A systematic review of the use of economic evaluation in local decision-making, Health Policy, 86, 129, 10.1016/j.healthpol.2007.11.010 Hoffmann, 2000, The influence of economic evaluation studies on decision making. A European survey. The EUROMET group, Health Policy, 52, 179, 10.1016/S0168-8510(00)00076-2 Hoffmann, 2002, Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities, Value Health, 5, 71, 10.1046/j.1524-4733.2002.52109.x Zwart-van Rijkom, 2000, Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project, PharmacoEconomics, 18, 149, 10.2165/00019053-200018020-00005 Ramsey, 2015, Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report, Value Health, 18, 161, 10.1016/j.jval.2015.02.001 Korthals-de Bos, 2004, Economic evaluations and randomized trials in spinal disorders: principles and methods, Spine, 29, 442, 10.1097/01.BRS.0000102683.61791.80 Petrou, 2011, Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting, BMJ (Clinical research ed), 342, d1548, 10.1136/bmj.d1548 van Dongen, 2019, What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations?, Expert Rev Pharmacoecon Outcomes Res, 1 van Dongen, 2014, Trial-based economic evaluations in occupational health: principles, methods, and recommendations, J Occup Environ Med, 56, 563, 10.1097/JOM.0000000000000165 Miyamoto, 2018, Different doses of Pilates-based exercise therapy for chronic low back pain: a randomised controlled trial with economic evaluation, Br J Sports Med, 10.1136/bjsports-2017-098825 Chiarotto, 2018, Core outcome measurement instruments for clinical trials in nonspecific low back pain, Pain, 159, 481, 10.1097/j.pain.0000000000001117 Gray, 2010 Petrou, 2011, Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting, BMJ, 342, d1766, 10.1136/bmj.d1766 Evers, 2015, Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies, Psychol Health, 30, 52, 10.1080/08870446.2014.953532 Roberts, 2012, Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force -2, Value Health, 15, 804, 10.1016/j.jval.2012.06.016 Siebert, 2012, State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3, Value Health, 15, 812, 10.1016/j.jval.2012.06.014 Eddy, 2012, Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7, Med Decis Making, 32, 733, 10.1177/0272989X12454579 Ramsey, 2005, Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report, Value Health, 8, 521, 10.1111/j.1524-4733.2005.00045.x Howards, 2018, An overview of confounding. Part 1: the concept and how to address it, Acta Obstet et Gynecol Scand, 97, 394, 10.1111/aogs.13295 Brouwer, 2006, A dollar is a dollar is a dollar—or is it?, Value Health, 9, 341, 10.1111/j.1524-4733.2006.00123.x Schreijenberg, 2017, Efficacy of paracetamol, diclofenac and advice for acute low back pain in general practice: design of a randomized controlled trial (PACE Plus), BMC Musculoskelet Disord, 18, 56, 10.1186/s12891-017-1432-5 Miyamoto, 2019, Cost-effectiveness of exercise therapy in the treatment of non-specific neck pain and low back pain: A systematic review with meta-analysis, Br J Sports Med, 53, 172, 10.1136/bjsports-2017-098765 Pinto, 2012, Cost-effectiveness of nonpharmacologic, nonsurgical interventions for hip and/or knee osteoarthritis: systematic review, Value Health, 15, 1, 10.1016/j.jval.2011.09.003 Tsertsvadze, 2014, Cost-effectiveness of manual therapy for the management of musculoskeletal conditions: a systematic review and narrative synthesis of evidence from randomized controlled trials, J Manipulative Physiol Ther, 37, 343, 10.1016/j.jmpt.2014.05.001 Nunes Cabral, 2021, Economic evaluations of educational, physical, and psychological treatments for fibromyalgia: A systematic review with meta-analysis, Pain Chiarotto, 2017, Core outcome sets for research and clinical practice, Braz J Phys Ther, 21, 77, 10.1016/j.bjpt.2017.03.001 Page, 2015, Core domain and outcome measurement sets for shoulder pain trials are needed: systematic review of physical therapy trials, J Clin Epidemiol, 68, 1270, 10.1016/j.jclinepi.2015.06.006 Choy, 2009, Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome, J Rheumatol, 36, 2330, 10.3899/jrheum.090368 Smith, 2019, Uptake of the OMERACT-OARSI hip and knee osteoarthritis core outcome set: review of randomized controlled trials from 1997 to 2017, J Rheumatol, 46, 976, 10.3899/jrheum.181066 Murray, 1997, Understanding DALYs (disability-adjusted life years), J Health Econ, 16, 703, 10.1016/S0167-6296(97)00004-0 Sassi, 2006, Calculating QALYs, comparing QALY and DALY calculations, Health Policy Plan, 21, 402, 10.1093/heapol/czl018 Torrance, 1995, Multi-attribute preference functions. Health Utilities Index, PharmacoEconomics, 7, 503, 10.2165/00019053-199507060-00005 Dolan, 1997, Modeling valuations for EuroQol health states, Med Care, 35, 1095, 10.1097/00005650-199711000-00002 Brazier, 2002, The estimation of a preference-based measure of health from the SF-36, J Health Econ, 21, 271, 10.1016/S0167-6296(01)00130-8 Whitehead, 2010, Health outcomes in economic evaluation: the QALY and utilities, Br Med Bull, 96, 5, 10.1093/bmb/ldq033 Cruz, 2011, Estimating the SF-6D value set for a population-based sample of Brazilians, Value Health, 14, S108, 10.1016/j.jval.2011.05.012 Briggs, 2001, The death of cost-minimization analysis?, Health Econ, 10, 179, 10.1002/hec.584 Drummond, 1996, Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ economic evaluation working party, BMJ, 313, 275, 10.1136/bmj.313.7052.275 Drummond, 2005, Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies, Int J Technol Assess Health Care, 21, 165, 10.1017/S0266462305050221 Uegaki, 2007, Consensus-based findings and recommendations for estimating the costs of health-related productivity loss from a company's perspective, Scand J Work Environ Health, 33, 122, 10.5271/sjweh.1115 Beemster, 2019, Test-retest reliability, agreement and responsiveness of Productivity Loss (iPCQ-VR) and Healthcare Utilization (TiCP-VR) Questionnaires for sick workers with chronic musculoskeletal pain, J Occup Rehabil, 29, 91, 10.1007/s10926-018-9767-9 Hoefman RJ, Van Exel NJA, Brouwer WBF. iVICQ. iMTA Valuation of Informal Care Questionnaire, version 1.1. http://www.bmg.eur.nl/english/imta/publications/questionnaires_manuals/ivicq/. Published 2013. Accessed. Database of Instruments for Resource Use Measurement. http://www.dirum.org/. Published 2020. Accessed. Goossens, 2000, The cost diary: a method to measure direct and indirect costs in cost-effectiveness research, J Clin Epidemiol, 53, 688, 10.1016/S0895-4356(99)00177-8 van den Brink, 2005, Self-reports of health-care utilization: diary or questionnaire?, Int J Technol Assess Health Care, 21, 298, 10.1017/S0266462305050397 Tompa, 2008 COFFITO: Conselho Federal de Fisioterapia e Terapia Ocupacional. http://coffito.gov.br/nsite/wp-content/uploads/2016/08/CartilhadeValoriza%C3%A7%C3%A3oProfissional_Fisioterapia_vers%C3%A3o01_04_2016.pdf. Updated August. Accessed 2017. Hakkaart-van Roijen, 2010 Oostenbrink, 2002, Standardisation of costs: the Dutch Manual for Costing in economic evaluations, PharmacoEconomics, 20, 443, 10.2165/00019053-200220070-00002 SIGTAP - Sistema de Gerenciamento da Tabela de Procedimentos. DATASUS. sigtap.datasus.gov.br. Updated April. Accessed 2017. Dakin, 2011, What is the value of collecting detailed costing data in clinical trials?, Trials, 12, A42, 10.1186/1745-6215-12-S1-A42 Rede Brasileira de Avaliação de Tecnologias em Saúde (REBRATS). Diretriz metodológica: Estudos de microcusteio aplicados a avaliações econômicas em saúde. REBRATS.https://rebrats.saude.gov.br/images/Documentos/Diretriz_Metodologica_Estudos_de_Microcusteio_Aplicados_a_Avaliacoes_Economicas_em_Saude.pdf. Accessed 2020. Frick, 2009, Microcosting quantity data collection methods, Med Care, 47, S76, 10.1097/MLR.0b013e31819bc064 Chapel, 2019, Understanding cost data collection tools to improve economic evaluations of health interventions, Stroke Vasc Neurol, 4, 214, 10.1136/svn-2019-000301 Clement Nee Shrive, 2009, The impact of using different costing methods on the results of an economic evaluation of cardiac care: Microcosting vs gross-costing approaches, Health Econ, 18, 377, 10.1002/hec.1363 Raftery, 2000, Costing in economic evaluation, BMJ, 320, 10.1136/bmj.320.7249.1597 Glick, 2007 van den Berg, 2004, Economic valuation of informal care. An overview of methods and applications, Eur J Health Econ, 5, 36, 10.1007/s10198-003-0189-y Zhang, 2011, Measuring and valuing productivity loss due to poor health: a critical review, Soc Sci Med, 72, 185, 10.1016/j.socscimed.2010.10.026 Krol, 2013, Productivity costs in economic evaluations: past, present, future, PharmacoEconomics, 31, 537, 10.1007/s40273-013-0056-3 Brouwer, 1997, Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion, Health Econ, 6, 511, 10.1002/(SICI)1099-1050(199709)6:5<511::AID-HEC297>3.0.CO;2-K Kessler, 2003, The world health organization health and work performance questionnaire (HPQ), J Occup Environ Med, 45, 156, 10.1097/01.jom.0000052967.43131.51 Brouwer, 1999, Productivity losses without absence: measurement validation and empirical evidence, Health Policy, 48, 13, 10.1016/S0168-8510(99)00028-7 Koopmanschap, 2005, PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies, Expert Rev Pharmacoecon Outcomes Res, 5, 23, 10.1586/14737167.5.1.23 Meerding, 2005, Health problems lead to considerable productivity loss at work among workers with high physical load jobs, J Clin Epidemiol, 58, 517, 10.1016/j.jclinepi.2004.06.016 Lerner, 2003, Relationship of employee-reported work limitations to work productivity, Med Care, 41, 649, 10.1097/01.MLR.0000062551.76504.A9 Lerner, 2001, The Work Limitations Questionnaire, Med Care, 39, 72, 10.1097/00005650-200101000-00009 Lerner, 2002, The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis, J Clin Epidemiol, 55, 197, 10.1016/S0895-4356(01)00424-3 Bouwmans, 2015, The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses, Value Health, 18, 753, 10.1016/j.jval.2015.05.009 Kigozi, 2017, The Estimation and inclusion of presenteeism costs in applied economic evaluation: a systematic review, Value Health, 20, 496, 10.1016/j.jval.2016.12.006 Instituto Brasileiro de Geografia e Estatística - IBGE. www.ibge.gov.br. Updated April. Accessed 2017. Turner, 2019, Adjusting for inflation and currency changes within health economic studies, Value Health, 22, 1026, 10.1016/j.jval.2019.03.021 Attema, 2018, Discounting in economic evaluations, PharmacoEconomics, 36, 745, 10.1007/s40273-018-0672-z Gravelle, 2001, Discounting for health effects in cost-benefit and cost-effectiveness analysis, Health Econ, 10, 587, 10.1002/hec.618 Goossens, 1999, Principles of economic evaluation for interventions of chronic musculoskeletal pain, Eur J Pain, 3, 343, 10.1016/S1090-3801(99)90016-2 Brouwer, 2005, Need for differential discounting of costs and health effects in cost effectiveness analyses, BMJ, 331, 446, 10.1136/bmj.331.7514.446 Barber, 1998, Analysis and interpretation of cost data in randomised controlled trials: review of published studies, BMJ, 317, 1195, 10.1136/bmj.317.7167.1195 Thompson, 2000, How should cost data in pragmatic randomised trials be analysed?, BMJ, 320, 1197, 10.1136/bmj.320.7243.1197 Bacchetti, 2005, Ethics and sample size, Am J Epidemiol, 161, 105, 10.1093/aje/kwi014 Gabrio, 2017, Handling missing data in within-trial cost-effectiveness analysis: a review with future recommendations, PharmacoEconomics, 1, 79, 10.1007/s41669-017-0015-6 Noble, 2012, Missing data in trial-based cost-effectiveness analysis: The current state of play, Health Econ, 21, 187, 10.1002/hec.1693 Diaz-Ordaz, 2014, Are missing data adequately handled in cluster randomised trials? A systematic review and guidelines, Clin Trials, 11, 590, 10.1177/1740774514537136 Sterne, 2009, Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls, BMJ, 338, b2393, 10.1136/bmj.b2393 Leurent, 2018, Sensitivity analysis for not-at-random missing data in trial-based cost-effectiveness analysis: A tutorial, PharmacoEconomics, 36, 889, 10.1007/s40273-018-0650-5 White, 2011, Multiple imputation using chained equations: Issues and guidance for practice, Stat Med, 30, 377, 10.1002/sim.4067 Barber, 2000, Analysis of cost data in randomized trials: an application of the non-parametric bootstrap, Stat Med, 19, 3219, 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P Kelley, 2005, The effects of nonnormal distributions on confidence intervals around the standardized mean difference: bootstrap and parametric confidence intervals, Educ Psychol Meas, 65, 51, 10.1177/0013164404264850 Chaudhary, 1996, Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial, Stat Med, 15, 1447, 10.1002/(SICI)1097-0258(19960715)15:13<1447::AID-SIM267>3.0.CO;2-V Robinson, 1993, Economic evaluation and health care. What does it mean?, BMJ, 307, 670, 10.1136/bmj.307.6905.670 Briggs, 2002, Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies, Ann Rev Public Health, 23, 377, 10.1146/annurev.publhealth.23.100901.140534 Black, 1990, The CE plane: a graphic representation of cost-effectiveness, Med Decis Making, 10, 212, 10.1177/0272989X9001000308 Appleby, 2007, NICE's cost effectiveness threshold, BMJ, 335, 358, 10.1136/bmj.39308.560069.BE Zwaap, 2015 World Health Organization, Marseille E, Larson B, Kazi D, Kahn J, Rosen S. Thresholds for the cost–effectiveness of interventions: Alternative approaches. https://www.who.int/bulletin/volumes/93/2/14-138206/en/. Published 2019. Accessed. Fenwick, 2006, Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation, BMC Health Serv Res, 6, 52, 10.1186/1472-6963-6-52 Fenwick, 2004, Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions, Health Econ, 13, 405, 10.1002/hec.903 Kashfi, 2019, The effects of deep neck muscle-specific training versus general exercises on deep neck muscle thickness, pain and disability in patients with chronic non-specific neck pain: protocol for a randomized clinical trial (RCT), BMC Musculoskelet Disord, 20, 540, 10.1186/s12891-019-2880-x Silva, 2019, Effects of neuromuscular training and strengthening of trunk and lower limbs muscles in women with Patellofemoral Pain: a protocol of randomized controlled clinical trial, blinded, Trials, 20, 586, 10.1186/s13063-019-3650-7 Pustivsek, 2019, Integral movement therapy versus local movement therapy approach in patients with idiopathic chronic low-back pain: study protocol for a randomized controlled trial, Trials, 20, 69, 10.1186/s13063-018-3128-z Australian Government, Department of Health. Health Technology Assessment (HTA). http://www.health.gov.au/internet/hta/publishing.nsf/Content/commonwealth-1. Published 2020. Accessed 24 Jul 2020. Ministerie van Volksgezondheid, Welzijn en Sport. ZIN. Zorginstituut Nederland - Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg.https://www.zorginstituutnederland.nl/publicaties/publicatie/2016/02/29/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg. Published 2016. Accessed 28 Mar 2018. Juch, 2017, Effect of radiofrequency denervation on pain intensity among patients with chronic low back pain: the Mint randomized clinical trials, JAMA, 318, 68, 10.1001/jama.2017.7918